XORTX Therapeutics
Stock Forecast, Prediction & Price Target
XORTX Therapeutics Financial Estimates
XORTX Therapeutics Revenue Estimates
XORTX Therapeutics EBITDA Estimates
XORTX Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| CA$0 N/A | CA$0 0% | CA$0 0% | Avg: CA$176.41M Low: CA$176.41M High: CA$176.41M avg. 0% | Avg: CA$74.39M Low: CA$74.39M High: CA$74.39M avg. -57.82% | Avg: CA$290.47M Low: CA$290.47M High: CA$290.47M avg. 290.42% | |
Net Income
% change YoY
| CA$-1.29M N/A | CA$-6.98M -439.31% | CA$-2.85M 59.08% | Avg: CA$-2.60M Low: CA$-2.60M High: CA$-2.60M avg. 8.83% | Avg: CA$-3.66M Low: CA$-3.66M High: CA$-3.66M avg. -40.62% | Avg: CA$65.24M Low: CA$65.24M High: CA$65.24M avg. 1880.00% | |
EBITDA
% change YoY
| CA$-4.12M N/A | CA$-10.63M -157.95% | CA$-6.46M 39.15% | Avg: CA$0 Low: CA$0 High: CA$0 avg. 100% | Avg: CA$0 Low: CA$0 High: CA$0 avg. 0% | Avg: CA$0 Low: CA$0 High: CA$0 avg. 0% | |
EPS
% change YoY
| -$1.19 N/A | -$4.72 -296.63% | -$1.44 69.49% | Avg: -$1.32 Low: -$1.32 High: -$1.32 avg. 8.65% | Avg: -$1.85 Low: -$1.85 High: -$1.85 avg. -40.62% | Avg: $32.93 Low: $32.93 High: $32.93 avg. 1880.00% | |
Operating Expenses
% change YoY
| CA$2.86M N/A | CA$9.86M 244.55% | CA$4.80M -51.27% | Avg: CA$0 Low: CA$0 High: CA$0 avg. -100% | Avg: CA$0 Low: CA$0 High: CA$0 avg. 0% | Avg: CA$0 Low: CA$0 High: CA$0 avg. 0% | |
FAQ
What is XORTX Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 616.07% in 2025-2027.
We have gathered data from N/A analysts. Their low estimate is -2.60M, average is -2.60M and high is -2.60M.
What is XORTX Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 77.53% in 2025-2027.
We have gathered data from N/A analysts. Their low revenue estimate is CA$176.41M, average is CA$176.41M and high is CA$176.41M.
What is XORTX Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 616.01% in 2025-2027.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$1.32, average is -$1.32 and high is CA$-1.31.